The expression of the regulatory (RI and RII) and catalytic (C) subunits of cAMP-dependent protein kinase was found to depend on the growth-state in oestrogen-dependent DMBA-induced mammary adenocarcinomas as well as in uteri of the rat. Castration-induced atrophy of the oestrogen-dependent tissues was accompanied by a decrease of the concentration of regulatory subunits (RI and RII) relative to both the catalytic subunit (C) and total protein, decreasing the R/protein and R/C ratios. A hyperplastic burst caused by high-dose oestrogen-replacement treatment was associated with an increased level of RI and little change in RII and C levels. Only minor differences were noted for the expression of mRNA for the a and P subtypes of RI, RII and C between rat uteri from castrated and oestrogen-treated animals, or between mammary tumours from normal and castrated animals. Expression of RIP-mRNA was detected only in the uterus. Our findings provide an experimental correlate for the reported value of the parameter R/protein in human mammary cancer biopsies to predict prognosis and outcome of therapy. Due to the sensitivity of the R/protein ratio towards changes in extracellular protein content, we recommend the biologically more meaningful R/C ratio in further clinical evaluations of mammary tumour biopsies.
The intracellular signal substance cAMP and its major eukaryotic effector system, the cAMP-dependent protein kinase (cAK), has a key role in regulating cell functions ranging from intermediary metabolism to cell shape and DNA replication. cAK is composed of a regulatory (R) subunit dimer and two catalytic (C) subunits. Except for a special form (Cy) of the catalytic subunit with mRNA expression in human testis (Beebe et al., 1990) , only two forms (a,p) are known of each type of regulatory (Rla, RIP; RIIa, RIIP) and catalytic (Ca, CP) subunit (see Beebe & Corbin, 1986; Edelman et al., 1987 , for general reviews of cAMP-kinase).
Recent evidence indicates that cells made to overexpress or underexpress specific subunits have altered growth characteristics, and that cAMP action on cell growth, cell differentiation and cell viability may depend on specific types or forms of the cAMP kinase (see Cho-Chung, 1990 for a review). Altered level of Rla-expression has recently been shown to be necessary for tissue-specific gene regulation in liver (Boshart et al., 1991; Jones et al., 1991) . Differential expression of cAK subunits can be on three levels: 1. Disproportionate accumulation of regulatory relative to catalytic subunits of cAK, changing the R/C ratio.
2. Altered ratio between the two isozymes of cAK (type I and type II).
3. Altered expression of the subforms (a and P) of each type (RI, RII, C) of subunit.
One of the main purposes of the present study was to find out if any specific type of expressional change correlated with tissue growth or regression in in vivo experimental models. This was done for the sake of the general interest in correlating cAK and growth, and to screen for parameters relating to cAK subunit expression which might prove useful to judge the growth potential in biopsies from human Correspondence: Dr Gunnar Houge, Department of Anatomy, Arstadveien 19, N-5009 Bergen, Norway. List of abbreviations used: cAMP = cyclic adenosine 3':5'-monophosphate; cAK = cAMP-kinase = cAMP-dependent protein kinase; R = the regulatory subunits of cAK; RI and RII = isozyme forms of the regulatory subunits of cAK; C = the catalytic subunit of cAK; DMBA = 7,12-dimethylbenz(x)anthracene; CRE = cAMP responsive element. Received 13 March 1992; and in revised form 15 June 1992.
tumours. Oestrogen-responsive normal and malignant tissue (uterus and DMBA-induced mammary carcinomas of the rat) were chosen as model systems. Isozyme specific antibodies were used to discriminate RI and RII, and Northern blots of mRNA were used to discriminate the subforms on the level of mRNA expression.
The experimental models were chosen partly because mammary carcinomas appear particularly interesting regarding cAK expression. The ratio between the concentrations of oestrogen receptor and R has appeared useful to predict the response to endocrine therapy. Both for human mammary carcinoma (Kvinnsland et al., 1983; Miller et al., 1985; Watson et al., 1987) and DMBA-induced mammary carcinoma in the rat (Bodwin et al., 1980) this parameter was more reliable than steroid receptor levels alone. Recently, tumour relapse rate and patient survival was found to correlate with the concentration of R subunits in tissue homogenates from human primary mammary tumours (Miller et al., 1990) . One purpose of the present study was to see if this simple parameter (concentration of R) was related to the growth response to oestrogen in experimental systems. This could provide a basis for understanding the apparent usefulness of this parameter. Another major purpose was to screen the more sophisticated parameters of cAK expression for correlation with growth state. [5': 8-3H] (Houge et al., 1990b (Bradford, 1976) , using bovine gamma globulin as the standard. It may be noted that the protein values obtained using this protein standard were about 2.5 times higher than with bovine serum albumin as the standard. The (Vintermyr & D0skeland, 1987) of the procedure of Patterson (Patterson, 1979) . Before spectrophotometric determination of DNA, an aliquot of the sample was removed to determine the amount of [methyl-3H]-thymidine incorporated into DNA by liquid scintillation counting.
Materials and methods

Materials
Isolation of total RNA and hybridization with cDNA probes Total RNA was isolated according to the procedure described by Chomczynsky et al. (Chomczynsky & Sacchi, 1987) . Mammary carcinoma tissue was homogenised with a Dounce tissue grinder in 1 ml of 25 mM sodium citrate buffer pH 7.0 containing 4 M guanidinium thiocyanate, 0.5% sodium lauroylsarcosine (w/v) and 1% 2-mercapto-ethanol (v/v). Rat uteri were homogenised in 2 ml of the above mentioned solution with a Polytron PT 10/35 homogeniser for 45 s (at a setting of 9). Further purification and Northern blotting of RNA was done as described previously (Houge et al., 1990a) . The RNA nylon membranes were hybridised with 32P-dCTP labelled probes made by random primed labelling of Rla-, RIP-, RIoa-, Rllp, Co-and CP-cDNA fragments. Autoradiography was performed with preflashed film at -70°C, 2-20 days exposure. The hybridisation signals were measured using the LKB UltroScan XL Laser Densitometer. Expression of cAMP-kinase subunits in uterine tissue Ovariectomy led as expected to a decline in uterine DNA synthesis and protein content (Figure 1 , lower two panels). In order to study in more detail the relation between cAK expression and oestrogen dependent growth, ten days postovariectomy rats were treated with high doses of 17p-estradiol to induce a transient increase in DNA synthesis. The DNA synthesis peaked 36 h after commencement of such treatment and approached uncastrated control level 12 h thereafter (Figure 1 ). The data are in agreement with the triggering by estradiol of one wave of coordinated DNA replication in the uterine epithelium (Figure 1, Figure 2b ). Uterine protein content and weight increased continuously during the period studied (Figure 1 ). Stromal oedema was microscopically evident after 1 day of estradiol treatment ( Figure 2b ). These findings established that the treatment used had the effect on uterus expected from a high dose estradiol regimen (Lavia et al., 1984; Lee, 1972; Martin et al., 1973; Stormshak et al., 1976) .
The uterine expression of the regulatory subunit of cAK isozyme I (RI) was sensitive to the endocrine state of the animal. RI decreased in response to castration, and transiently increased in response to high-dose estradiol treatment. In contrast, the concentration of the C subunit of cAK was constant (when expressed relative to uterine protein) during oestrogen treatment, and RII showed only minor fluctuations. Therefore, the values of the derived parameters RI/Rll and R/C (Figure 1 ) decreased after castration and increased during the first 36 h of estradiol treatment. These parameters correlated thus positively with the burst of DNA replication. The increasing amount of tissue oedema in the endometrium presumably led to accumulation of extracellular serum-derived proteins invalidating the protein determinations as a measure of intracellular protein. Presumably this was why the R/protein data did not show the same clear correlation with DNA synthesis as RI/Rll and R/C (data not shown).
The uterine cAMP-kinase was mainly cytosolic, i.e. only 7% of total RI and 13% of total RII were found in the particulate fraction in either castrated or oestrogenised uteri (data not shown). There was therefore no indication of growth associated translocation of protein kinase subunits between the soluble and particulate compartments.
The antibodies used to separate RI and RII do not discriminate between the a and 13 subtypes of RI and RII. In order to know if estradiol treatment specifically affected the expression of a particular subtype of RI or RII, the amounts of mRNA for both the a-and P-subtypes of RI and RII were determined on Northern blots (Figure 3 ). The rat uterus was found to contain mRNA for both subtypes of RI and RII. The mRNA coding for the a-subtype of RI was at least ten times more abundant than the RIP-mRNA. The difference in mRNA level for the a and P RII subtype was less, but still in favour of the a-subtype. There were no major differences in relative expression of subtypes upon estradiol treatment with the exception of the RII3-mRNA level which was transiently increased 12 h after oestrogen replacement (Figure 3) . It is not known if this increase in RIIP-mRNA was accompanied by an increase in RIIP protein because rat-RIIP specific antibodies were not available. Judged by the RIIa-and RIIPmRNA signal intensities and the exposure times (Figure 3) , it is likely that RIIa is the dominating RII subtype in the uterus. The finding that no increase in RII protein level was found 12 or 24 h after oestrogen-stimulation gives this assumption further credit. The presence of RI,B-mRNA in uterus is of interest, since this particular subtype has been considered specific for brain and testis (Clegg et al., 1988; Massa et al., 1990) (Figure 3) . No CP-mRNA was detected on the same Northern blots.
cAMP-kinase isozyme expression in DMBA-induced rat mammary tumours
The findings for rat uterus (preceding paragraph) showed a correlation between growth changes and expression of particular protein kinase subunits. It was of interest to find if similar correlation existed in other hormone-dependent systems, like the oestrogen-dependent DMBA-induced mam- mary carcinoma. For this, biopsies from subcutaneously growing tumours were removed before castration and ten days after castration and analysed for size, DNA synthesis and expression of protein kinase subunits (Table I) . One hour before tumour biopsies were taken, the rats were intraperitoneally injected with 5 mg of the protease inhibitor leupeptin. This was to protect the protein kinase subunits against proteolytic breakdown during the process of tumour removal, tissue freezing and homogenisation. Histological analysis of several tumours showed typical adenocarcinomas with sparse connective tissue (Figure 2d-f ; see also Cohen & Chan, 1975) . Autoradiography confirmed that DNA synthesis was chiefly in the tumour cells and that the DNA synthetic activity in these cells decreased after castration. Table I shows that ten days after ovariectomy the DNA replicative activity and the average tumour size had decreased about three fold. Both R/protein and R/C had decreased significantly. The decrease of the concentration of total R was due to a decrease of both RI and RII. The level of C did not change significantly. There was no evidence of altered distribution of protein kinase subunits between particulate and soluble fractions (data not shown).
Northern blot analysis of total RNA revealed a low level of RIIP-mRNA expression and higher levels of mRNAs for the a-subforms of RI, RII and C (Figure 3 (Figure 4 ; see also Meites, 1972; Escrich, 1987) . As shown in Figure 4 the pattern of expressional change of cAMP-kinase subunits was similar to that observed in the oestrogen treated rat uterus (Figure 1) (Figure 2f) . None of the tumours showed necrotic areas. The only apparent difference between the cAK expression parameters in long-term treated uteri and carcinomas was a slower return of the estradiol-induced increase of RI/Rll ratio in the former (Figures 1,4) .
As explained in the Materials and methods section six biopsies of mammary tumours were taken from animals treated with N6-monobutyryl cAMP. This was done to see if cAMP could induce the same increase in R/C ratio as observed in other systems (Schwoch, 1987; Houge et al., 1990a) . A cAMP-induced increase in R/C was found due to an increase of RII and to a lesser extent of RI (Table II) . No change was found in the level of C or the DNA-synthetic activity.
Discussion
The biological significance of an increased cAMP level can only be fully understood if the state of the cAMP-effector system, the cAMP-dependent protein kinase, is known. Usually, the proportion between R and C is close to 1:1 in normal tissue (Hofmann et al., 1977) . However, hepatocytes undergoing compensatory hyperplasia after partial hepatectomy (Ekanger et al., 1989) and parotid epithelial cells induced to proliferate by isoproterenol (Schwoch, 1987) increase their R/C ratio before DNA replication. In the present study, an increased R/G-ratio was found to correlate positively with proliferation of both rat uterine cells and rat mammary carcinoma cells (Figures 1,4 ; Table I ). An increased R/C ratio may therefore accompany increased growth of epithelial cells (both normal and malignant) in vivo. CC An increased R/C-ratio results in a higher threshold for kinase activation, i.e. the amount of cAMP required for liberation of a certain amount of active C will be elevated.
The equilibrium: R2C2 + 4(cAMP) = R2(cAMP)4 + 2C is shifted to the left. In addition, the extra R will serve as a sink for cAMP (for a theoretical discussion of the effect of an altered R/C ratio, see Houge et al., 1990a) . Even a modest change in free C may have dramatic biological effects assuming that cAK participates in a finely tuned system of phosphorylation and dephosphorylation. This means that cells with an increased R/C ratio will show partial resistance to cAMP. A good illustration of this point has recently arrived from the experiments done to find the tissue specific extinguisher (TSE1) in liver cells (Boshart et al., 1991; Jones et al., 1991) . After 10 years of research, the TSE1 turned out to be RIa. When liver cell Rla level is reduced at the time of birth, some genes with cAMP responsive elements in their promoters are turned on. If hepatoma cells are fused with cells more strongly expressing Rla (e.g. fibroblasts), these tissue specific liver genes are turned off again.
The consequence of the partial cAMP resistance resulting from increased R/C ratio depends on the effect of elevated cAMP on cell growth. This is still imperfectly known and to some extent controversial (Boynton & Whitfield, 1983; Gottesman & Fleischmann, 1986) . Normal hepatocytes have a biphasic response, i.e. stimulation by moderate cAMP and inhibition by strongly elevated cAMP (Br0nstad et al., 1983; Vintermyr et al., 1989; Thoresen et al., 1990 ). In the regenerating rat liver we have proposed that the prereplicative cAMP surge (MacManus et al., 1972) acts to inhibit the G1/S transition, and that the block in late GI is overcome partly because of the increased R/C ratio occurring prereplicatively (Ekanger et al., 1989) . A similar mechanism may operate in the case of the isoproterenol-stimulated proliferation of parotid gland epithelium (Schwoch, 1987) . In the case of human mammary carcinoma cell lines the findings are controversial (Handschin & Eppenberger, 1979; Eppenberger et al., 1980; Prasad, 1981; Handschin et al., 1983; Israeli et al., 1985) . Using an oestrogen responsive MCF-7 cell line, we first failed to obtain effects on DNA replication of cAMP elevating agents and cAMP analogues. However, when the phosphodiesterase activity of the cells was blocked a clear inhibition of DNA replication by cAMP could be demonstrated. Furthermore, microinjection of the C subunit of cAMP-dependent protein kinase led to inhibition of DNA replication (0. Vintermyr, A. Aakvaag & S.O. D0skeland, unpublished observations). The current evidence suggest to us that the growth associated increase of R/C ratio observed in liver (Ekanger et al., 1989) , parotid (Schwoch, 1987) , and uterus and mammary carcinoma (the present study) serves to protect cells against negative modulation of DNA replication by cAMP. The importance of downregulation of cAK for cell cycle progression is further supported by a recent study using microinjection of an inhibitor of cAK into fibroblasts (Lamb et al., 1991) .
The mechanism of the increased R/C ratio may in principle be an increase of either RI or RII or a decrease of C subunit.
In the case of the oestrogen-stimulated uterus and DMBAinduced mammary carcinomas the increase was mainly due to increased expression of RI (Figures 1,4) . In mammary carcinomas from animals treated with cAMP-analogue RII and to a lesser extent RI showed increased expression (Table   II) . This difference suggests that the oestrogen-dependent overexpression of RI was not secondary to increased cAMP.
In growth-stimulated DMBA-induced mammary tumours, both the RI and RII levels were higher than in oestrogendeprived tumours (Table I) , a situation reminiscent of the findings in the prereplicative regenerating rat liver, where both RI and RII rose to increase the R/C ratio (Ekanger et al., 1989) . It is noteworthy that a decrease of C did not contribute to the growth-associated increased R/C ratio in the DMBA-tumours (Table I) . A slight decrease of C contributed to the increased R/C-ratio in prereplicative regenerating rat liver (Ekanger et al., 1989) , whereas decreased C was the main contributor to the increased R/Cratio in isoproterenol-stimulated rat parotid cells (Schwoch, 1987) , cAMP-stimulated hepatocytes in primary culture (Houge et al., 1990a) and porcine kidney cells (Hemmings, 1986) , e.g. in cells stimulated by cAMP. However, a decrease in C due to strong cAMP-stimulation is not compulsory. In this study, no decrease in C was found after treating uncastrated rats with cAMP-analogue (Table II) . Similar findings have been done in various cell culture systems (Prasad, 1981; Lohmann & Walter, 1984; Gross et al., 1990; Landmark et al., 1991; Lanotte et al., 1991) . A parameter which has been positively associated with growth in studies dating back more than a decade (D0ske-land et al., 1975; Russel, 1978; Cho-Chung, 1990 ) is the RI/RII ratio. In the present study the oestrogen-induced burst of DNA-synthesis was associated with increased RI/RII ratio (Figures 1,4) , but the correlation was too weak to be statistically significant for the DMBA-tumours (Table I ). The latter finding was somewhat suprising. In human mammary carcinomas the RI/RII ratio was found to be higher than in adenomas as judged by DEAE cellulose chromatography (Eppenberger et al., 1980) . It may be noted, as a general precaution when comparing studies of cAK isozyme expres- sion, that the use of DEAE-cellulose to separate RI-holoenzyme from RII-holoenzyme is more error-prone (Malkinson et al., 1983) than the use of antibodies (Ekanger & D0skeland, 1987 (Tortora et al., 1991) . The uterine RI/RII ratio stayed elevated after the initial burst of oestrogen-induced DNA replication, i.e. when the uterus grew by hypertrophy rather than hyperplasia (Figure 1 ). Such a hypertrophy-associated increase of RI/RII ratio has also been found in the heart (Russel, 1978) and liver (Ekanger et al., 1988) . A possible explanation, supported by the findings in rat liver (Ekanger et al., 1988) , is that hypertrophying cells preferentially increase RI to keep their cytoplasmic concentration of R on a constant level. A preferential increase of RI was also found in transfected fibroblasts overexpressing the C subunit (Uhler & McKnight, 1987 ). It appears thus that although the present study contributes additional examples of association between increased RI/Rll ratio and increased DNA synthesis and cell hypertrophy, such a correlation is not obligatory (e.g. Wittmaack, et al., 1983 ).
This study did not provide indication of differential cAK subtype function in relation to growth, based on mRNA studies (Figure 3) . If the mRNA level of Ca is used as a reference, the only clear evidence of differential mRNA expression found was a three fold increase in uterine RIIPmRNA 12 h after onset of high-dose oestrogen stimulation (Figure 3 ). High inducibility of RIIP-mRNA has also been found in Friends erythroleukaemia cells, where RIIP-mRNA was stabilised post-transcriptionally after activation of cAK (Gross et al., 1990) . It is not known if the increase in R1IP-mRNA can be linked to increased cAMP level in our case. It is noteworthy that RIP-mRNA was detected on conventional Northern blots in the uterus. RIP-mRNA has previously only been found in the brain and germ cells (Clegg et al., 1988; Massa et al., 1990) , and the significance of its expression in uterus is not known. However, recent experiments with holoenzymes reconstituted with Rhaand RIP, have shown the latter to be more sensitive to activation by cAMP (Cadd et al., 1990 ). An overexpression of RI,B relative to RIh would therefore be expected to lower the threshold of the kinase towards activation by cAMP.
In the clinical setting the oestrogen receptor/R was a better parameter than oestrogen receptor/protein in predicting a tumour's response to endocrine therapy (Kvinnsland et al., 1983) . In addition the parameter R/protein (or total cAMP binding capacity) has been shown to be an independent prognostic factor for patients with early breast cancer (Miller et al., 1990) . In the present experimental study the ratios R/protein and R/C were tightly associated because the C subunit level was nearly constant (Figure 4 ; Table I ). As reviewed above there is an increasing number of in vivo examples of increased R/C ratio in cells in transition from a resting state to a proliferating state (Figures 1,4 ; Table I ). The increased R/C will protect the cells from negative regulation of proliferation by cAMP (D0skeland et al., 1991) . Possibly, mammary tumours with increased R expression have increased resistance to endocrine therapy.
The parameter R/protein depends on the determination of protein in an extract of tumour which may contain extracellular proteins and debris of protein nature from necrotic cells. This may explain why the R/protein values differ in different parts of the same tumour (Miller et al., 1985) . Since the amount of C subunit reflects the content of a cell protein, and the ratio between R and C subunits has biological significance, the R/C ratio may be a better parameter than R/protein for clinical purposes.
It was noted that ageing of tissue extracts led to rapid loss of immunoreactive RII, whereas total R (determined by direct cAMP binding capacity) was much more stable. This was presumably because tissue proteases clipped the cAMP binding domain from the aminoterminal domain containing the epitopes recognised by the antibodies. In the clinical setting, proteolysis can be a major problem for the accurate determination of RI and especially RII. In the present study several precautions were taken to avoid the loss of immunoreactive R: The tissue was freeze-clamped at the temperature of liquid nitrogen, grinded in liquid nitrogen and kept in that medium until homogenisation. Special care was taken to inhibit proteases during the homogenisation and immunoprecipitation, involving the use of an extensive protease-inhibitor cocktail (see methods) and doing all the work on ice or in the cold-room. As an extra precaution the rats in this study were intraperitoneally injected with leupeptin 1 h before tumour removal.
In summary, the direct determination of R and C is simpler and 'safer' than the separate measurement of RI and RII. RI, RII or RI/RII shows no better correlation with growth than R or R/C ( Table I ). The R level should be referred to the C level to calculate the biologically significant R/C ratio and to have a reference for R that is methodologically less problematic than protein measurements.
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